Anandamide in Health and Disease 1st Edition

Grab attention with cutting-edge insight into a molecule reshaping neuroscience and medicine. Anandamide in Health and Disease (1st Edition) by Bernard Le Foll delivers a clear, authoritative exploration of the endocannabinoid anandamide—its biology, clinical implications, and therapeutic potential for disorders ranging from pain and addiction to mood and neurodegeneration.

Dive into a carefully structured narrative that balances rigorous science with clinical relevance. Le Foll synthesizes preclinical and human research to explain how anandamide signaling affects brain function, immune response, and systemic health. Chapters guide readers through molecular mechanisms, diagnostic challenges, pharmacological modulation, and emerging treatment strategies—making complex topics accessible to neuroscientists, clinicians, pharmacologists, and advanced students.

Imagine applying insights from this book to inform research design, guide clinical decision-making, or spark translational projects. With practical discussions of biomarkers, therapeutic targets, and safety considerations, the text empowers professionals across psychiatry, neurology, pain medicine, and pharmacology to better understand and leverage endocannabinoid biology.

Whether you are in North America, Europe, Asia-Pacific, or Latin America, this volume offers globally relevant content grounded in contemporary science. Its professional yet engaging tone makes it an essential reference for researchers, clinicians, and graduate-level readers seeking a comprehensive, up-to-date look at anandamide’s role in health and disease.

Enhance your library with Bernard Le Foll’s authoritative 1st Edition—order now to stay at the forefront of endocannabinoid research and clinical application.

Note: eBooks do not include supplementary materials such as CDs, access codes, etc.